Gilead Sciences

The scheme was to find discarded HIV pill bottles, fill them with fake meds, and reseal them before selling them to unsuspecting victims.

The FDA and legal authorities are trying to figure out who’s behind the brand-name knock-offs. In the meanwhile, the fake meds could make people dangerously ill.

A major clinical trial shows getting a shot every other month can be just as effective as taking a daily pill.

“We have seen people come off ventilators a day after starting therapy.”

The government says it owns some patents on the HIV medication regimen & is owed royalties.

This move will allow the medication to get into many more hands.

Activists hailed the earlier than expected release, calling it “a victory for the LGBTQ+ community, for HIV activists, and for U.S. taxpayers.”

Because the drug was developed using federal funds, the National Institute of Health has the option of breaking the patent and allowing generic versions to come to market.

The first ad features three groups heavily affected by HIV: youth of color, transgender women, and gay men.

The move took advocates by surprise, since it wasn’t expected until 2021. However, the announcement has led to confusion about how soon it might be available.

The makers of a breakthrough drug for hepatitis C put profits before patients in pricing the $1,000 pill that cures the liver-wasting disease.

FOSTER CITY, Calif. — Gilead Sciences Inc. said Monday that the Food and Drug Administration rejected two marketing applications for HIV treatments, citing quality control problems at the company’s manufacturing facilities.